Novozymes reported 484.6M in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Arq USD 21.68M 7.08M Mar/2026
Avient USD 609.4M 34.6M Jun/2026
Chemours USD 1.31B 136M Jun/2026
Coronado Global Resources USD 517.59M 12.28M Mar/2026
Corteva USD 2.91B 380M Jun/2026
Metallus USD 261.3M 9.6M Dec/2025
Newmont Corporation USD 2.57B 25M Mar/2026
Novozymes 484.6M 46.8M Mar/2026
SSR Mining USD 204.72M 20.58M Jun/2026